BlackRock Group’s Keryx Biopharmaceuticals Inc KERX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q4 | $324K | Buy |
55,363
+5,555
| +11% | +$32.5K | ﹤0.01% | 2491 |
|
|
2016
Q3 | $263K | Buy |
49,808
+2,379
| +5% | +$12.6K | ﹤0.01% | 2521 |
|
|
2016
Q2 | $314K | Sell |
47,429
-794
| -2% | -$5.26K | ﹤0.01% | 2411 |
|
|
2016
Q1 | $225K | Buy |
48,223
+12,536
| +35% | +$58.5K | ﹤0.01% | 2517 |
|
|
2015
Q4 | $180K | Sell |
35,687
-1,061
| -3% | -$5.35K | ﹤0.01% | 2536 |
|
|
2015
Q3 | $129K | Buy |
36,748
+4,605
| +14% | +$16.2K | ﹤0.01% | 2631 |
|
|
2015
Q2 | $321K | Buy |
32,143
+6,601
| +26% | +$65.9K | ﹤0.01% | 2416 |
|
|
2015
Q1 | $326K | Buy |
25,542
+4,799
| +23% | +$61.3K | ﹤0.01% | 2327 |
|
|
2014
Q4 | $293K | Buy |
20,743
+1,850
| +10% | +$26.1K | ﹤0.01% | 2397 |
|
|
2014
Q3 | $259K | Sell |
18,893
-529
| -3% | -$7.25K | ﹤0.01% | 2361 |
|
|
2014
Q2 | $299K | Sell |
19,422
-17,262
| -47% | -$266K | ﹤0.01% | 2337 |
|
|
2014
Q1 | $624K | Buy |
36,684
+6,429
| +21% | +$109K | ﹤0.01% | 2141 |
|
|
2013
Q4 | $392K | Buy |
+30,255
| New | +$392K | ﹤0.01% | 2260 |
|